The North America Protein Expression Market would witness market growth of 9.4% CAGR during the forecast period (2022-2028).
Molecular biology research uses a variety of enzymes and proteins, many of which are from expression systems. These systems have important uses in industrial fermentation, particularly in the synthesis of enzymes and biopharmaceuticals such as human insulin for the treatment of diabetes. Bacteria, yeast, mammalian cells, baculovirus/insect, and more recently filamentous fungus like Myceliophthora thermophila, are examples of commonly utilized protein synthesis systems. When any of these systems are used to create biopharmaceuticals, trace levels of host cell proteins, which are process-related contaminants, are also present in the finished product.
Cell-based expression systems are the most well-established and popular ones. They can be summed up as the combination of a vector of expression, its cloned DNA, and the host for a vector that provides a framework to allow foreign genetic mechanisms in a host cell. Overexpression is a high level of gene expression that is excessively and abnormally high and results in a clear phenotype that is related to the gene. The other method for protein synthesis is the cell-free system. Utilizing ribosomes, tRNA, ribonucleotides, and purified RNA polymerase, cell-free protein creation is carried out in vitro. These chemicals may be made via cell extraction or a cell-based expression system.
Since North America has the most developed healthcare infrastructure and the highest level of R&D activity, it is the region with the greatest expansion potential for protein expression. The protein expression industry in the US is driven by a number of factors, including a rise in the use of protein technologies, the region's rapidly developing pharmaceutical industry, and the presence of numerous enterprises there.
The US market dominated the North America Protein Expression Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.3 billion by 2028. The Canada market is registering a CAGR of 11.9% during (2022-2028). Additionally, The Mexico market would experience a CAGR of 10.9% during (2022-2028).
Based on System, the market is segmented into Prokaryotic, Mammalian Cell, Insect Cell, Yeast, and Others. Based on Product, the market is segmented into Reagents, Competent Cells, Instruments, Services, and Others. Based on Application, the market is segmented into Therapeutic, Industrial, Research. Based on End-user, the market is segmented into Pharmaceutical & Biotechnological Companies, Academic Research, Contract Research Organizations, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck Group, New England BioLabs, Inc., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and LGC Biosearch Technologies.
Molecular biology research uses a variety of enzymes and proteins, many of which are from expression systems. These systems have important uses in industrial fermentation, particularly in the synthesis of enzymes and biopharmaceuticals such as human insulin for the treatment of diabetes. Bacteria, yeast, mammalian cells, baculovirus/insect, and more recently filamentous fungus like Myceliophthora thermophila, are examples of commonly utilized protein synthesis systems. When any of these systems are used to create biopharmaceuticals, trace levels of host cell proteins, which are process-related contaminants, are also present in the finished product.
Cell-based expression systems are the most well-established and popular ones. They can be summed up as the combination of a vector of expression, its cloned DNA, and the host for a vector that provides a framework to allow foreign genetic mechanisms in a host cell. Overexpression is a high level of gene expression that is excessively and abnormally high and results in a clear phenotype that is related to the gene. The other method for protein synthesis is the cell-free system. Utilizing ribosomes, tRNA, ribonucleotides, and purified RNA polymerase, cell-free protein creation is carried out in vitro. These chemicals may be made via cell extraction or a cell-based expression system.
Since North America has the most developed healthcare infrastructure and the highest level of R&D activity, it is the region with the greatest expansion potential for protein expression. The protein expression industry in the US is driven by a number of factors, including a rise in the use of protein technologies, the region's rapidly developing pharmaceutical industry, and the presence of numerous enterprises there.
The US market dominated the North America Protein Expression Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.3 billion by 2028. The Canada market is registering a CAGR of 11.9% during (2022-2028). Additionally, The Mexico market would experience a CAGR of 10.9% during (2022-2028).
Based on System, the market is segmented into Prokaryotic, Mammalian Cell, Insect Cell, Yeast, and Others. Based on Product, the market is segmented into Reagents, Competent Cells, Instruments, Services, and Others. Based on Application, the market is segmented into Therapeutic, Industrial, Research. Based on End-user, the market is segmented into Pharmaceutical & Biotechnological Companies, Academic Research, Contract Research Organizations, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck Group, New England BioLabs, Inc., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and LGC Biosearch Technologies.
Scope of the Study
Market Segments Covered in the Report:
By System
- Prokaryotic
- Mammalian Cell
- Insect Cell
- Yeast
- Others
By Product
- Reagents
- Competent CellsInstruments
- Services
- Others
By Application
- Therapeutic
- Industrial
- Research
By End User
- Pharmaceutical & Biotechnological Companies
- Academic Research
- Contract Research Organizations
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Merck Group
- New England BioLabs, Inc.
- Promega Corporation
- Qiagen N.V.
- Takara Bio, Inc. (Takara Holdings Inc.)
- Oxford Expression Technologies Ltd.
- LGC Biosearch Technologies
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Protein Expression Market by System
Chapter 5. North America Protein Expression Market by Product
Chapter 6. North America Protein Expression Market by Application
Chapter 7. North America Protein Expression Market by End-user
Chapter 8. North America Protein Expression Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Merck Group
- New England BioLabs, Inc.
- Promega Corporation
- Qiagen N.V.
- Takara Bio, Inc. (Takara Holdings Inc.)
- Oxford Expression Technologies Ltd.
- LGC Biosearch Technologies
Methodology
LOADING...
